Quarterly ResultMay 15, 2026, 06:18 AM
TDAC Q1 Net Income $1.33M; Going Concern Doubt Raised
AI Summary
Translational Development Acquisition Corp. (TDAC) reported a net income of $1.33 million for Q1 2026, a decrease from $1.48 million in Q1 2025, with basic and diluted net income per share falling to $0.06 from $0.07. The company's management raised substantial doubt about its ability to continue as a going concern due to liquidity issues and the mandatory liquidation deadline of June 24, 2026, if a business combination is not completed. Cash decreased to $24,630, and the company increased its promissory note from a related party to $500,000 to fund operations.
Key Highlights
- Management raised substantial doubt about going concern due to mandatory liquidation by June 24, 2026.
- Net income for Q1 2026 was $1.33 million, down from $1.48 million in Q1 2025.
- Basic and diluted net income per Class A share was $0.06, down from $0.07 in Q1 2025.
- Cash balance decreased to $24,630 as of March 31, 2026, from $29,787 at year-end 2025.
- Promissory note from related party increased to $500,000 from $200,000 as of December 31, 2025.
- Marketable securities in Trust Account increased to $183.27 million from $181.66 million.
- Total current liabilities increased to $861,085 from $544,073.
Price Impact
More from TDAC